Clinical trial

Botulinum Toxin Injection in the Treatment of Open Abdomen

Name

7/2020

Description

Botulinum toxin has been widely approved and utilized in the treatment of complex abdominal wall hernias. Botulinum toxin has been only randomly studied in the treatment of open abdomen.

Trial arms

Trial start

2020-02-21

Estimated PCD

2024-06-01

Trial end

2024-08-01

Status

Recruiting

Treatment

Botulinum Toxins

Botulinum toxin injection to abdominal wall

Arms:

Botox injection

Size

Primary endpoint

Abdominal wall closure

30 days

Eligibility criteria

Inclusion Criteria: * Open abdomen Exclusion Criteria: * Previous incisional hernia in midline * Patient is not in active treatment

Protocol

{'studyType': 'OBSERVATIONAL', 'patientRegistry': True, 'targetDuration': '30 Days', 'designInfo': {'observationalModel': 'CASE_CONTROL', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 30, 'type': 'ESTIMATED'}}

Updated at

2024-02-01

1 organization

1 product

2 indications

Organization

Product

Indication

Indication